Mahboob Vaseem 4

What Happened Mahboob Vaseem, Chief Financial Officer of Kestra Medical Technologies, Ltd. (KMTS), was issued 44,118 common shares on July 15, 2026 pursuant to the vesting of performance-based restricted stock units (PSUs). The transaction is reported on an SEC Form 4 as an award/acquisition (code A) with an acquisition price of $0.00 (as reported on the form).

Key Details

• Transaction date: July 15, 2026; Form 4 filed July 17, 2026 (timely filing).
• Reported acquisition: 44,118 shares at $0.00 per share (total acquisition value reported as $0 on the form).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: These shares represent performance-based RSUs ("PSUs") granted July 17, 2025; 100% of the PSUs vested on July 15, 2026 (per footnote F1).
• No sale or open-market disposition reported in this filing.

Context These were vested performance awards (PSUs), not a market purchase or sale—such awards reflect compensation tied to company performance rather than an insider buying or selling stock. The Form 4 reports the award acquisition price as $0.00; to estimate the economic value to the insider, investors can reference KMTS market price around the July 15, 2026 vesting date.